TrialBlood2025

Safety and efficacy of rilzabrutinib vs placebo in adults with immune thrombocytopenia: the phase 3 LUNA3 study.

David J Kuter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.